Back to the full story2 sources · STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more◆ All Sources
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
1 region · 2 outlets · 3 reports — every source grouped by where each outlet is based. Region reflects only headquarters, not the subject of the report.
Other
3 articles · 2 outlets
STATAug 24, 1:36 PM
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
STATAug 24, 11:59 AM
STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
Fierce BiotechAug 24, 11:51 AM
Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings